AstraZeneca Vaccine 'Protects Against Severe Disease, Death'
The Malawi government has announced that it has decided to go ahead with acquiring the Oxford-AstraZeneca Covid-19 vaccine, despite concerns about its efficacy. Alarm bells went off In South Africa, when clinical trials at the University of Witwatersrand in Johannesburg, concluded that the AstraZeneca vaccine provided only "minimal" protection against mild to moderate Covid-19 symptoms caused by the 501.V2 variant. South Africa, Africa's hardest-hit nation, was due to start its vaccination campaign with a million AstraZeneca doses but halted the plans, and may instead switch to a different vaccine. Meanwhile, the World Health Organization has warned against dismissing the vaccine, insisting it was still a vital tool in the global fight against the novel coronavirus pandemic.
As of August 21, 2022, confirmed cases of Covid-19 from 55 African countries reached 12,126,067 while 373,195,217 vaccinations have been administered across ... Read more »
South Africa is to suspend its rollout of the Oxford-AstraZeneca vaccine after initial trials showed "disappointing" results against the new B.1.351 variant of Covid-19. The ... Read more »
The COVAX vaccine-sharing facility has allocated at least 330 million doses of Covid-19 vaccines for poorer countries and aims to deliver these and millions more in the first half ... Read more »
A more aggressive second wave of Covid-19 has put pressure on Zimbabwe's dysfunctional public health system, and further eroded confidence in the ability of the government to ... Read more »
South African President Cyril Ramaphosa addressed the nation on February 1, 2021, announcing the easing of some novel coronavirus pandemic lockdown restrictions. Ramaphosa said ... Read more »
Africa needs timely access to safe and effective Covid-19 vaccines (file photo).